
Photo from Michael Hofman/X
May 24, 2024, 12:32
Michael Hofman: PRIMARY2 clinical trial: patient 400 of 660 recruited
Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre shared on X:
“PRIMARY2 clinical trial: patient 400 of 660 (60%) recruited. Incredible effort by an amazing team led by Louise Emmett with James Buteau, Daniel Moon, Declan Murphy, Renu Eapen, Matt Roberts plus many others around Australia.” .
Read further.
Source: Michael Hofman/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00